Since January 22nd, 2026, Accellix is part of bioMérieux, a world leader in the field of in vitro diagnostics.
Learn more about this strategic acquisition.
Videos
Presentations
Tutorials
Presentations
Advantages of Cellular Starting Material Characterization for Allogeneic Cell Therapy Applications: Impacts to Downstream In-Process Cell Therapy Adaptive Manufacturing
Félix A. Montero-Julian (Accellix)
Aniha Vijay Kumar (Excellos)
Chase P. Monckton (Excellos)
(2025)
Aniha Vijay Kumar (Excellos)
Chase P. Monckton (Excellos)
(2025)
Innovations Across the Cell Therapy Workflow: From Apheresis to Analysis
Félix A. Montero-Julian (Accellix)
Trevor Smith (Terumo)
Jenny Sander (WellSky)
AABB Biotherapies Pavilion (2025)
Trevor Smith (Terumo)
Jenny Sander (WellSky)
AABB Biotherapies Pavilion (2025)
Potency Assays and Functional Characterisation – Going Hand-in-Hand during Product Development up to Commercial Licensing
Félix A. Montero-Julian (Accellix)
Therese Choquette (Tigen Pharma)
Ulrike Herbrand (Charles River Laboratories)
(2025)
Therese Choquette (Tigen Pharma)
Ulrike Herbrand (Charles River Laboratories)
(2025)
Overcoming Challenges Faced with Traditional Flow Cytometry in Cell Therapy Manufacturing with the Accellix Automated Flow Cytometer
Rey Mali (Accellix)
Matthias Heemskerk (Galapagos)
(2023)
Matthias Heemskerk (Galapagos)
(2023)
Implementation of advanced QC testing solutions for Cell and Gene therapy manufacturing
Irving Ford (BMS)
Rhessa Diaz (BMS)
Félix A. Montero-Julian (bioMérieux)
ISCT (2021)
Rhessa Diaz (BMS)
Félix A. Montero-Julian (bioMérieux)
ISCT (2021)
Value of the QC testing in ATMP: when rapid time to results matters
Rey Mali (Accellix)
Félix A. Montero-Julian (bioMérieux)
(2021)
Félix A. Montero-Julian (bioMérieux)
(2021)
Connect with Accellix at these events:
International Society for Cell & Gene Therapy (ISCT) 2026
May 6, 2026 – May 9, 2026
Dublin, Ireland
